Articles
Navigating Russia’s Compliance Regulations; Arguably the Most Complex in...
Russia’s increasing reliance on pharmaceutical-driven healthcare is resulting in a growing consumer demand for drugs of all types.
Over the past few decades, the country’s domestic...
Research Insight
Lonza and AllCells Join Forces for Global Commercialization of...
Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. ...
Research Insight
New Study Findings Show Mixture of DuPont Probiotic Strains...
New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing the...
Research Insight
WuXi AppTec Expands Site in California for Pharmaceutical R&D...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in...
Research Insight
Eisai and UCLommence preparations for phase i clinical studies...
Eisai Co., Ltd and University College London  announced that they have commenced preparations for Phase I clinical studies on E2814 The first...
Research Insight
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment syndicate...
Research Insight
Protagen AG collaborates with UCSF to study better immuno-profiling...
Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.